Re: Any results yet of Herceptin (Trastuzumab) adjuvant Breast Cancer trials?

From: Steph (steph_at_vancouver.island)
Date: 08/26/04


Date: Thu, 26 Aug 2004 06:07:54 GMT


"BJ" <Xforestcat@hotmail.com> wrote in message
news:f8bqi09u3a3njsvsafb3gp726o7v8a9ehk@4ax.com...
> There are some ongoing trials that intend to evaluate the use of
> Herceptin (Trastuzumab) in the adjuvant setting for women having had
> breast cancer and who test positive for HER-2. The researchers are
> looking into whether it would be a good idea to give wimen Herceptin
> (Trastuzumab) after initial chemo and radiation to decrease the risk
> for the cancer to return.
>
> As I have a long-term girlfriend who have got breast cancer I would be
> most interested in any interimistic results of these trials, if any
> are at hand. In my country there is only one trial (the HERA trial)
> that is possible for her to participate in. In that trial there is a
> chance of one in three that she will not get any Herceptin.
>
> I would be very interested in knowing if it would be worth the cost
> and hard work to get her on Herceptin off-protocol if she gets into
> the arm which has no Herceptin.
>

You don't understand what a clinical trial is...........
If it was certain that herceptin was better, there would be no need for a
trial



Relevant Pages

  • Re: "Hewitt steps into cancer drug row"
    ... Herceptin is not licensed for early breast cancer ... The medical journal The Lancet has said claims for the anti-cancer drug ... Herceptin should be treated with greater caution. ... Herceptin, which can cost £20,000 a year for a course of treatment, is ...
    (soc.men)
  • When it comes to Herceptin, some healthy skepticism is, well, quite healthy.
    ... The breast cancer drug trastuzumab (better known by its brand name ... Herceptin) has had more than its share of good press. ... Providing Herceptin to a select group of breast cancer patients would ... the risk of recurrence by half. ...
    (sci.med.diseases.cancer)
  • Re: rastuzumab/Herceptin
    ... The breast cancer drug trastuzumab (better known by its brand name ... Herceptin) has had more than its share of good press. ... Providing Herceptin to a select group of breast cancer patients would ... the risk of recurrence by half. ...
    (sci.med.diseases.cancer)
  • Any results yet of Herceptin (Trastuzumab) adjuvant Breast Cancer trials?
    ... Herceptin (Trastuzumab) in the adjuvant setting for women having had ... As I have a long-term girlfriend who have got breast cancer I would be ... signs of distant metastases yet. ...
    (sci.med.diseases.cancer)
  • Re: [OT] Its a bit fucked up isnt it?
    ... Herceptin is not given to everyone with breast cancer. ... of potentially life saving drugs for cancer sufferers. ...
    (uk.rec.motorcycles)